Tenaya Therapeutics, Inc. (TNYA)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Tenaya Therapeutics, Inc. (TNYA)
Go deeper and ask any question about TNYA
Company Performance
Current Price
as of Sep 13, 2024$2.00
P/E Ratio
N/A
Market Cap
$157.78M
Description
Tenaya Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics for cardiovascular diseases. It operates through its product platforms: gene therapy, cellular regeneration, and precision medicine. The company was founded by Deepak Srivastava, Benoit G. Bruneau, Bruce R. Conklin, Sheng Ding, Saptarsi Haldar, and Eric Olson in 2016 and is headquartered in South San Francisco, CA.
Metrics
Overview
- HQSouth San Francisco, CA
- SectorHealth Technology
- IndustryPharmaceuticals: Major
- TickerTNYA
- Price$2-2.91%
Trading Information
- Market Cap$157.78M
- Float82.78%
- Average Daily Volume (1m)383,863
- Average Daily Volume (3m)402,896
- EPS-$1.57
Company
- RevenueN/A
- Rev Growth (1yr)N/A
- Net Income-$29.43M
- Gross MarginN/A
- EBITDA MarginN/A
- EBITDA-$28.70M
- EV$181.96M
- EV/RevenueN/A
- P/EN/A
- P/SN/A
Documents
SEC Filings
Factset Street Account